Thyroid Disease in Pregnancy: Workplace Accommodations, Trimester-Specific Targets, and What You Can Actually Do

Why Thyroid Function Changes So Dramatically During Pregnancy

Pregnancy rewires thyroid physiology from the first weeks onward. Your thyroid is not simply "the same but pregnant." The changes begin before most women even know they have conceived.

Human chorionic gonadotropin (hCG), which surges in the first trimester, shares structural similarity with thyroid-stimulating hormone (TSH). This cross-reactivity stimulates the thyroid directly, causing TSH to drop and free T4 to rise transiently. By the second trimester, rising estrogen nearly doubles thyroid-binding globulin (TBG), which binds more T4 and pulls free T4 down, increasing the demand on the gland. The American Thyroid Association's 2017 guidelines on thyroid disease in pregnancy describe this cascade in detail and are the primary clinical reference used throughout this article.

Renal iodine clearance increases by 30 to 50 percent during pregnancy, raising iodine requirements just when the fetus also needs maternal iodine to build its own thyroid. Plasma volume expansion dilutes circulating hormones further. The net result is that a thyroid gland that was functioning adequately before pregnancy may struggle to keep up.

What This Means If You Already Have Hypothyroidism

If you take levothyroxine before pregnancy, studies show that 50 to 85 percent of women need a dose increase during pregnancy, often by 25 to 50 mcg. The increase typically becomes necessary by weeks four to six. Waiting for a routine prenatal appointment at week eight or ten to check TSH can allow weeks of suboptimal control during the most sensitive window for fetal brain development. Ask your prescriber for a TSH check the moment a pregnancy test is positive.

What This Means If You Have Hyperthyroidism or Graves Disease

Graves disease, the most common cause of hyperthyroidism in women of reproductive age, can actually improve in the second trimester as immune tolerance increases during pregnancy, then flare postpartum when immune suppression lifts. Propylthiouracil (PTU) is preferred in the first trimester because methimazole carries a small risk of embryopathy (aplasia cutis, choanal atresia). After the first trimester, switching to methimazole is typically recommended because PTU carries a rare but serious hepatotoxicity risk. Your endocrinologist and OB-GYN should coordinate this transition actively.

PCOS and Hashimoto: A Common Combination

Women with PCOS have a higher prevalence of autoimmune thyroid disease, including Hashimoto thyroiditis, than the general population. One meta-analysis in Fertility and Sterility found thyroid autoimmunity in approximately 26.0% of women with PCOS compared with about 8 percent of controls. If you have PCOS and are pregnant, thyroid antibody status and TSH should both be checked early, since positive TPO antibodies independently increase the risk of miscarriage even when TSH is technically normal.

Trimester-by-Trimester TSH Targets You Need to Know

Getting TSH into the right range for each trimester is not a single target you set and forget. It shifts as pregnancy progresses, and the lab range printed on your standard blood report almost certainly does not reflect pregnancy-specific thresholds.

The 2017 American Thyroid Association guidelines recommend the following trimester-specific TSH targets:

| Trimester | TSH Target | |---|---| | First (weeks 1 to 12) | <2.5 mIU/L | | Second (weeks 13 to 26) | <3.0 mIU/L | | Third (weeks 27 to 40) | <3.0 mIU/L |

Why the First Trimester Target Is Tighter

The fetal thyroid does not produce hormones independently until approximately weeks 10 to 12. Before that, your T4 crosses the placenta and is the sole source of thyroid hormone for your developing baby's brain. Even subclinical hypothyroidism in the first trimester, defined as TSH above trimester-specific limits with normal free T4, is associated with a modestly increased risk of preterm birth, placental abruption, and lower offspring IQ scores in some observational studies.

The CATS trial (Clinical Study of Thyroid Screening and Treatment) found that screening and treating subclinical hypothyroidism during pregnancy did not significantly improve child cognitive outcomes at age three, which introduced nuance into this space. The TABLET trial similarly found that levothyroxine did not improve live birth rates in euthyroid women with thyroid antibodies. These trials matter because they tell you where evidence is solid versus extrapolated. The strongest evidence supports treating overt hypothyroidism (elevated TSH plus low free T4). For subclinical hypothyroidism, treatment is still recommended by the ATA when TSH is above 2.5 mIU/L in the first trimester, even though the cognitive benefit is debated.

Monitoring Frequency

Once TSH is in range and dose is stable, the ATA recommends checking TSH every four weeks through mid-pregnancy, then once around weeks 26 to 32. This schedule is more frequent than typical non-pregnant adult monitoring (every six to twelve months) and is worth advocating for explicitly at your appointments.

Medication Safety in Pregnancy and Lactation

Levothyroxine

Levothyroxine is the standard treatment for hypothyroidism in pregnancy. It is not associated with teratogenicity when kept within the therapeutic range. The FDA does not assign it a formal letter category under the current labeling system, but it is classified as an essential medication in pregnancy with a well-established safety record. The goal is to replicate normal maternal thyroid physiology, not to overshoot.

Practical note: take levothyroxine on an empty stomach, 30 to 60 minutes before food or coffee. Calcium supplements and iron (both common in prenatal vitamins) interfere with absorption significantly. Take your prenatal vitamin at least four hours apart from levothyroxine.

PTU and Methimazole in Pregnancy

PTU is the preferred antithyroid drug in the first trimester. Methimazole has a small but documented association with a specific pattern of birth defects when used in the first trimester, including methimazole embryopathy characterized by aplasia cutis congenita and tracheoesophageal fistula. After week 16, switching to methimazole is standard practice to avoid PTU-associated liver injury.

Both drugs cross the placenta and can affect fetal thyroid function, so the goal is to use the lowest effective dose. Radioactive iodine is absolutely contraindicated in pregnancy and for six months before a planned pregnancy.

Lactation Transfer

Levothyroxine transfers into breast milk in very small amounts and is considered safe during lactation. The LactMed database notes that levothyroxine concentrations in breast milk are low and consistent with normal physiologic levels, and supplementing maternal thyroid hormone does not appear to suppress infant thyroid function.

PTU transfers into breast milk at low levels and is generally considered acceptable during lactation with monitoring. Methimazole also transfers but at slightly higher levels; the ATA states that methimazole up to 20 to 30 mg per day is compatible with breastfeeding with infant thyroid monitoring if doses are higher.

How to Manage Thyroid Disease in Pregnancy Naturally: What the Evidence Actually Shows

"Naturally" managing thyroid disease in pregnancy does not mean avoiding medication. Undertreated overt hypothyroidism during pregnancy carries documented risks including miscarriage, preterm birth, and impaired fetal neurodevelopment. Natural support means optimizing the conditions under which your thyroid functions, alongside appropriate medical care.

Iodine: Essential, But Not Unlimited

The WHO recommends 250 mcg of iodine daily during pregnancy and lactation. The U.S. Recommendation sits at 220 mcg during pregnancy and 290 mcg during lactation. Most prenatal vitamins contain 150 mcg or less. The American Thyroid Association recommends that pregnant and lactating women take a prenatal vitamin containing 150 mcg of iodine daily as potassium iodide, not kelp or seaweed supplements, because the iodine content of kelp is highly variable and can cause paradoxical hypothyroidism or hyperthyroidism.

If you have Hashimoto thyroiditis, high iodine intake may worsen autoimmune activity. Stay within recommended ranges rather than supplementing beyond them.

Selenium

Selenium is a cofactor for the enzymes that convert T4 to active T3, and it also supports the antioxidant defenses of the thyroid gland. A 2016 Cochrane review found insufficient evidence to recommend selenium supplementation routinely in pregnancy, but selenium deficiency is associated with postpartum thyroiditis. Food sources including Brazil nuts (one to two per day provides approximately 100 mcg), eggs, and seafood are appropriate ways to meet the recommended 60 mcg daily requirement during pregnancy. Avoid supplemental selenium above 400 mcg daily, which is toxic.

Vitamin D

Low vitamin D is strongly associated with Hashimoto thyroiditis and higher TPO antibody titers. A randomized controlled trial published in the Journal of Clinical Endocrinology and Metabolism found that vitamin D supplementation reduced TPO antibody levels in hypothyroid patients. Pregnancy itself reduces vitamin D, and deficiency is common, particularly in women with darker skin tones, limited sun exposure, or obesity. Most prenatal vitamins contain 400 to 600 IU of vitamin D3, which is often insufficient. Ask your provider to check your 25-hydroxyvitamin D level and supplement to achieve a level of 40 to 60 ng/mL.

Stress, Sleep, and the HPA-Thyroid Axis

Chronic stress elevates cortisol, which suppresses TSH secretion from the pituitary and reduces peripheral T4-to-T3 conversion. In pregnancy, already-disrupted sleep compounds this. This is not a reason to dismiss stress as "just lifestyle." It is a physiologically real pathway. Sleep support, whether through side-lying positioning, pillows for symphysis pubis pain, or treating pregnancy-related restless legs, directly supports thyroid axis function.

Foods That Can Interfere With Thyroid Function

Raw cruciferous vegetables in large amounts contain goitrogens, compounds that can mildly inhibit thyroid peroxidase. Cooking deactivates most goitrogens. You do not need to avoid broccoli or kale during pregnancy, but eating a pound of raw kale daily while undertreated for hypothyroidism is not a neutral choice.

Soy products, consumed in large quantities, may reduce levothyroxine absorption. Standard servings of soy foods are not clinically significant, but soy-based protein shakes taken close to thyroid medication can reduce absorption.

Workplace Accommodations for Thyroid Disease in Pregnancy

Thyroid disease in pregnancy can cause symptoms severe enough to affect your ability to do your job. Fatigue from hypothyroidism, palpitations and heat intolerance from hyperthyroidism, and hyperemesis-like nausea during medication adjustment are real, not imaginary. You have legal protections, and you are allowed to use them.

Your Legal Framework in the United States

Two federal laws apply directly.

The Pregnant Workers Fairness Act (PWFA), which took effect June 27, 2023, requires covered employers (those with 15 or more employees) to provide reasonable accommodations for known limitations related to pregnancy, childbirth, or related medical conditions. The EEOC's final rule implementing the PWFA explicitly includes pregnancy-related conditions such as fatigue, nausea, and medical appointments as covered limitations. Thyroid disease diagnosed during pregnancy qualifies.

The Americans with Disabilities Act (ADA) may also apply. Thyroid conditions that substantially limit a major life activity, such as fatigue that limits concentration or endurance, can qualify as disabilities under the ADA's broad post-ADAAA definition. Pregnancy-related thyroid dysfunction that is severe meets this threshold for many women.

Accommodations You Can Request

The following accommodations are reasonable under the PWFA and ADA framework for thyroid disease in pregnancy. Your employer does not have to provide every one, but must engage in an "interactive process" to find workable solutions:

• Flexible start times. Morning hypothyroid fatigue is worst on waking. A later start or compressed four-day week reduces this burden.
• Remote work options. Temperature dysregulation from hyperthyroidism or hypothyroidism is worse in office environments you cannot control. Working from home allows you to manage your environment.
• Frequent rest breaks. The PWFA specifically lists rest as a covered accommodation. For women with hypothyroid fatigue or hyperthyroid palpitations, a 10-minute seated rest every two hours is a documented accommodation.
• Private space for medication timing. Levothyroxine must be taken 30 to 60 minutes before eating, which can conflict with early meetings. A quiet space or adjusted schedule for this is reasonable.
• Modified duties during dose adjustments. The four to six weeks after a dose change can involve transitional symptoms including cognitive fog, mood changes, and variable energy. Temporarily reducing high-stakes cognitive tasks during this window is appropriate to request.
• Time off for monitoring appointments. TSH checks every four weeks are medically required. The PWFA protects time off for these appointments.

How to Request an Accommodation

Bring a letter from your OB-GYN or endocrinologist describing your diagnosis, the functional limitations it causes (specifically: fatigue limiting sustained attention, temperature sensitivity affecting concentration, required medication timing, frequency of medical appointments), and the accommodations they recommend. You do not need to disclose your full diagnosis to your employer, only enough to establish a work-related limitation.

Human resources departments are required to maintain your medical information separately from your personnel file under the ADA.

If Your Workplace Is Not Cooperative

File a charge with the Equal Employment Opportunity Commission (EEOC) within 180 days of a denial (or 300 days in states with their own anti-discrimination agencies). The PWFA is new, and many HR departments are not yet fully trained on its requirements. Being specific, documented, and formal in writing strengthens your position significantly.

Postpartum Thyroid Disease: The Stage Most Often Missed

Postpartum thyroiditis affects approximately 5 to 10 percent of women in the first year after delivery, making it one of the most common autoimmune conditions in the postpartum period. It is dramatically underdiagnosed.

The classic pattern is a transient hyperthyroid phase one to four months postpartum, followed by a hypothyroid phase four to eight months postpartum, followed by spontaneous recovery in most women. But the pattern is variable. Some women experience only the hypothyroid phase, which is frequently mistaken for postpartum depression.

Women with TPO antibodies in the first trimester have a 30 to 50 percent risk of developing postpartum thyroiditis. Women with type 1 diabetes have approximately a threefold increased risk. If you had Hashimoto disease before pregnancy, check TSH at your six-week postpartum visit and again at three to six months, not only at the one-year mark.

Breastfeeding during postpartum thyroiditis is safe. Symptoms including extreme fatigue, depression unresponsive to standard treatment, hair loss, and cold intolerance in a postpartum woman warrant a TSH check before attributing everything to "new mom exhaustion."

Who This Is Right for and Who Needs a Different Approach

Women Who May Need More Aggressive Monitoring

• You have a TSH above 10 mIU/L at any point in pregnancy: this is overt hypothyroidism and requires prompt levothyroxine initiation regardless of free T4.
• You have positive TPO or anti-thyroglobulin antibodies with a TSH between 2.5 and 10: treatment may be offered, and close monitoring is mandatory.
• You have a personal or family history of autoimmune thyroid disease, type 1 diabetes, prior pregnancy loss, or prior preterm birth.
• You were treated for hyperthyroidism within the past twelve months: relapse risk in pregnancy is elevated.

Women for Whom Lifestyle Support Alone Is Not Appropriate

If you have overt hypothyroidism (TSH above the trimester-specific upper limit with low free T4), no amount of iodine, selenium, stress management, or dietary change will substitute for levothyroxine. These strategies support thyroid health and medication efficacy; they are not alternatives. Delaying medication to "try natural first" during pregnancy carries risk to fetal neurodevelopment that cannot be recovered later.

Women With Subclinical Hypothyroidism

This is the genuinely gray zone. TSH mildly above trimester targets with normal free T4. The CATS trial found no significant difference in child IQ at age three between treated and untreated women with subclinical hypothyroidism. The ATA still recommends treatment when TSH exceeds 2.5 mIU/L in the first trimester because the cognitive data is imperfect, placental and obstetric outcomes data favor treatment, and the risk of levothyroxine at physiologic doses is minimal. This is a conversation to have explicitly with your provider rather than a question with a single correct answer for every woman.

Iodine, Supplements, and What to Avoid in Pregnancy

The supplement market for thyroid health contains several products that are inappropriate or potentially harmful during pregnancy.

The ATA specifically warns against using kelp, bladderwrack, and other seaweed-based supplements because iodine content is unpredictable and excess iodine in pregnancy can cause fetal goiter and hypothyroidism. One case report documented neonatal hypothyroidism from maternal seaweed supplement use.

Desiccated thyroid extract (DTE, sold as Armour Thyroid or NatureThroid) contains both T4 and T3. T3 crosses the placenta poorly and the T3 surge from DTE dosing does not replicate normal maternal physiology. The ATA recommends levothyroxine monotherapy as the preferred treatment in pregnancy, not DTE. If you were stable on DTE before pregnancy, this is worth discussing with your endocrinologist early, as switching to levothyroxine during pregnancy is typically recommended.

Biotin (vitamin B7) supplements, commonly taken for hair loss (a frequent hypothyroid symptom), interfere with thyroid lab assays and can cause falsely low TSH and falsely abnormal free T4 readings. The FDA issued a safety communication on this in 2019. Stop biotin for at least 48 to 72 hours before any thyroid blood draw.